APA aipamena

Noblejas-López, M. d. M., Nieto-Jimenez, C., Burgos, M., Gómez-Juárez, M., Montero, J. C., Esparís-Ogando, A., . . . Ocaña, A. (2019). Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer. J Exp Clin Cancer Res.

Chicago Style aipamena

Noblejas-López, María del Mar, Cristina Nieto-Jimenez, Miguel Burgos, Mónica Gómez-Juárez, Juan Carlos Montero, Azucena Esparís-Ogando, Atanasio Pandiella, Eva M. Galán-Moya, and Alberto Ocaña. "Activity of BET-proteolysis Targeting Chimeric (PROTAC) Compounds in Triple Negative Breast Cancer." J Exp Clin Cancer Res 2019.

MLA aipamena

Noblejas-López, María del Mar, et al. "Activity of BET-proteolysis Targeting Chimeric (PROTAC) Compounds in Triple Negative Breast Cancer." J Exp Clin Cancer Res 2019.